Summary of long-acting methylphenidate (MPH) formulations MPH formulation Synonyms Product availability Modified-release technology Immediate-release: extended-release ratio (%) ...

The FDA is revising the labeling of all extended-release ADHD medications to warn about adverse reactions in patients younger ...

In a large head-to-head trial, the response rate for methylphenidate (56%) was superior to that of atomoxetine (45%) for children and teens with ADHD.

This post-hoc analysis demonstrates why JORNAY PM is not substitutable with other methylphenidate products on a milligram per milligram basis; for example, the optimized JORNAY PM dose at 69.2 mg ...

NextWave has another oral extended-release methylphenidate formulation in its pipeline, a chewable tablet. NWP09 is in Phase III clinical trials, with an NDA submission planned for next year.

The article, “Effect of a Multi‑Layer, Extended‑Release Methylphenidate Formulation (PRC‑063) on Sleep in Adults with ADHD: A Randomized, Double‑Blind, Forced‑Dose, ...

Two new formulations of drugs traditionally used to treat attention deficit/hyperactivity disorder (ADHD), methylphenidate and d-amphetamine, last longer and have less potential for abuse ...

Some people have to call around pharmacies to get their script filled, others change to different medications. And the ...

Shire plc announced study results that suggested that stimulant medications such as Adderall XR (mixed salts of a single-entity amphetamine product) are significantly more effective than ...

The absorption of sustained-release methylphenidate formulations compared to an immediate-release formulation. Biopharm Drug Dispos. 1989;10(2):165-171. Newsletter ...

A phase 3 study of children ages 6-12 years with attention deficit/hyperactivity disorder (ADHD) has shown that a delayed-release, long-acting formulation of the stimulant methylphenidate, when ...